Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNP as Adjuvant Therapy in Heart Failure with Renal Dysfunction
NCT00170183Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2003
- Primary completion
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of nesiritide in heart failure (HF), sponsored by Mayo Clinic. Started Mar 2003; status: completed.
02
Drugs
nesiritide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00170183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170183.